Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous funding/operating status notice (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T12:39:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T07:35:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary is now available, and the page includes updated metadata such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' along with 'No FEAR Act Data', replacing the previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:38:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed on the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:31:52.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Florida, New Jersey, New York, and Pennsylvania, removed the separate state location subsections, and updated the page to revision v3.3.3 with the HHS Vulnerability Disclosure link removed.
    Difference
    0.6%
    Check dated 2025-12-23T08:20:16.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated from v3.3.1; this is a minor site version change with no impact on study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:36:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.